MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cara Therapeutics Company Profile (NASDAQ:CARA)

Consensus Ratings for Cara Therapeutics (NASDAQ:CARA) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.60 (85.39% upside)

Analysts' Ratings History for Cara Therapeutics (NASDAQ:CARA)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2015Piper JaffraySet Price TargetBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Needham & Company LLCSet Price TargetBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Canaccord GenuityReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Needham & Company LLCInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Canaccord GenuityReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Needham & Company LLCReiterated RatingBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015MLV & Co.Initiated CoverageBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Canaccord GenuityInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014Summer StreetInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014Canaccord GenuityBoost Price Target$25.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014Needham & Company LLCInitiated CoverageBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Stifel NicolausInitiated CoverageBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Canaccord GenuityInitiated CoverageBuy -> Buy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Janney Montgomery ScottInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Piper JaffrayInitiated CoverageOverweight$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/3/2013 forward)